US Broker Ratings

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: A 31% Potential Upside in the Biotech Sector

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands out in the biotechnology sector, particularly for individual investors seeking opportunities within the healthcare market. With its focus on developing..

Xenon Pharmaceuticals (XENE): Analyst Consensus Sees 43% Upside in Biotech Innovator

Investors seeking opportunities in the burgeoning biotechnology sector may find Xenon Pharmaceuticals Inc. (NASDAQ: XENE) an intriguing prospect. With a market capitalization of $2.97 billion, this..

Surgery Partners, Inc. (SGRY) Investor Outlook: Analyzing a 78.59% Potential Upside in the Healthcare Sector

In the dynamic landscape of healthcare investments, Surgery Partners, Inc. (NASDAQ: SGRY) stands out with its intriguing potential for growth and an impressive 78.59% potential upside..

Akero Therapeutics, Inc. (AKRO) Stock Analysis: Exploring Growth Potential Amid Metabolic Innovations

As Akero Therapeutics, Inc. (NASDAQ: AKRO) continues its pioneering work in the biotechnology sector, investors are keenly eyeing the company’s strategic positioning in the healthcare industry...

Krystal Biotech, Inc. (KRYS) Stock Report: Navigating Growth with a Potential 10.9% Upside

Krystal Biotech, Inc. (NASDAQ: KRYS), a prominent player in the biotechnology sector, is capturing investor attention with its promising pipeline and a notable potential upside of..

Cytokinetics (CYTK) Stock Analysis: Investors Eye 29.93% Upside on Biotech’s Promising Pipeline

Cytokinetics, Incorporated (NASDAQ: CYTK), a biopharmaceutical company focused on addressing muscle diseases, has continued to capture investor attention with its robust pipeline of drug candidates targeting..

Vaxcyte, Inc. (PCVX) Stock Analysis: Strong Upside Potential of 135% Amid Promising Vaccine Innovations

Vaxcyte, Inc. (NASDAQ: PCVX) is capturing the attention of investors with its promising pipeline of vaccines aimed at combating bacterial infectious diseases. As a clinical-stage biotechnology..

Axsome Therapeutics, Inc. (AXSM) Investor Outlook: Analyzing a 31% Upside Potential in the Biotech Sector

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a prominent player in the biotechnology sector, is capturing investor attention with its robust pipeline of therapies targeting central nervous system..

Soleno Therapeutics, Inc. (SLNO) Investor Outlook: Exploring a Potential 147.73% Upside

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is making waves in the biotechnology sector with its focus on developing novel treatments for rare diseases. With a market capitalization..

TG Therapeutics, Inc. (TGTX) Stock Analysis: 37% Potential Upside Draws Investor Attention

TG Therapeutics, Inc. (NASDAQ: TGTX), with a market capitalization of $5.12 billion, is making waves in the biotechnology sector, particularly for its focus on innovative treatments..

Nuvalent, Inc. (NUVL) Stock Analysis: A 34.55% Potential Upside in Biotech Innovations

For investors seeking opportunities in the biotechnology sector, Nuvalent, Inc. (NASDAQ: NUVL) presents a compelling case. With a market capitalization of $6.79 billion, this clinical-stage biopharmaceutical..

ADMA Biologics Inc (ADMA) Stock Analysis: Uncovering Nearly 88% Growth Potential Amid Robust Analyst Ratings

ADMA Biologics Inc (NASDAQ: ADMA), a prominent player in the biotechnology industry, is capturing significant attention with its substantial growth potential. With a market capitalization of..

Alkermes plc (ALKS) Stock Analysis: A 33% Upside Potential and Robust Revenue Growth in the Biopharma Sector

Alkermes plc (NASDAQ: ALKS), an Ireland-based biopharmaceutical company, is attracting considerable attention from investors due to its strong positioning in the healthcare sector, particularly within the..

BridgeBio Pharma, Inc. (BBIO) Stock Analysis: Unveiling a 34% Upside Potential in the Biotech Sector

BridgeBio Pharma, Inc. (BBIO), a prominent player in the biotechnology sector, is drawing investor attention with its substantial market cap of $11.91 billion and a compelling..

Glaukos Corporation (GKOS) Investor Outlook: Unlocking a 43.69% Potential Upside in Medical Devices

Glaukos Corporation (NYSE: GKOS) stands out in the healthcare sector as a dynamic player in the medical devices industry, focusing on innovative treatments for ophthalmic conditions...

Elanco Animal Health (ELAN) Stock Analysis: Exploring a 8.30% Upside Potential

Elanco Animal Health Incorporated (NYSE: ELAN), a leader in the healthcare sector’s drug manufacturing for both specialty and generic products, is showcasing promising growth potential for..

Option Care Health, Inc. (OPCH) Stock Analysis: Healthcare Growth and a 27% Upside Potential

Option Care Health, Inc. (OPCH), a prominent player in the healthcare sector, offers investors a unique opportunity within the medical care facilities industry. With a market..

Integer Holdings Corporation (ITGR): Investor Outlook with 24% Potential Upside

Integer Holdings Corporation (NYSE: ITGR), a key player in the healthcare sector, specifically within the medical devices industry, presents an intriguing opportunity for investors seeking exposure..

Jazz Pharmaceuticals plc (JAZZ) Investor Outlook: Exploring a 44% Potential Upside

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the biotechnology sector, offers an intriguing investment opportunity with its substantial potential upside of 44.01%. Headquartered in..

Legend Biotech Corporation (LEGN) Stock Analysis: Unveiling a 136% Potential Upside in the Biotech Sector

Legend Biotech Corporation (NASDAQ: LEGN) has been capturing attention in the biotechnology sector with its innovative approach to cell therapy, particularly in oncology. Despite the stock’s..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds